Li Xia manages real-time operations on his farm using a suspended computer screen while lying in bed on Feb 10. [Photo by Deng Rui/China Daily] In the picturesque outskirts of northwestern Chongqing, ...
Oral PrimeC for ALS significantly reduced toxic TDP-43 protein levels in a Phase 2b trial. PrimeC also slowed functional decline and extended survival by about 15 months. The treatment was well ...
TRCN-1023, an experimental treatment for ALS, aims to restore UNC13A function. It is designed to improve communication between nerves and muscles. Global Phase 1/2 clinical trials are underway to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results